Follow
Frank Oechslin
Frank Oechslin
Verified email at ulaval.ca
Title
Cited by
Cited by
Year
Phage diversity, genomics and phylogeny
MB Dion, F Oechslin, S Moineau
Nature Reviews Microbiology 18 (3), 125-138, 2020
6262020
Resistance development to bacteriophages occurring during bacteriophage therapy
F Oechslin
Viruses 10 (7), 351, 2018
4452018
Synergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence
F Oechslin, P Piccardi, S Mancini, J Gabard, P Moreillon, JM Entenza, ...
The Journal of infectious diseases 215 (5), 703-712, 2017
3152017
Metagenome analysis of Russian and Georgian Pyophage cocktails and a placebo‐controlled safety trial of single phage versus phage cocktail in healthy Staphylococcus aureus carriers
S McCallin, SA Sarker, S Sultana, F Oechslin, H Brüssow
Environmental microbiology 20 (9), 3278-3293, 2018
1052018
In vitro characterization of PlyE146, a novel phage lysin that targets Gram-negative bacteria
Y Larpin, F Oechslin, P Moreillon, G Resch, JM Entenza, S Mancini
PLoS One 13 (2), e0192507, 2018
902018
In Vitro Characterization of PlySK1249, a Novel Phage Lysin, and Assessment of Its Antibacterial Activity in a Mouse Model of Streptococcus agalactiae Bacteremia
F Oechslin, J Daraspe, M Giddey, P Moreillon, G Resch
Antimicrobial agents and chemotherapy 57 (12), 6276-6283, 2013
602013
Genotypes of Staphylococcus aureus: On-farm epidemiology and the consequences for prevention of intramammary infections
A Leuenberger, C Sartori, R Boss, G Resch, F Oechslin, A Steiner, ...
Journal of dairy science 102 (4), 3295-3309, 2019
522019
Spatial structure affects phage efficacy in infecting dual-strain biofilms of Pseudomonas aeruginosa
S Testa, S Berger, P Piccardi, F Oechslin, G Resch, S Mitri
Communications biology 2 (1), 405, 2019
482019
Efficacy of newly isolated and highly potent bacteriophages in a mouse model of extensively drug-resistant Acinetobacter baumannii bacteraemia
L Leshkasheli, M Kutateladze, N Balarjishvili, D Bolkvadze, J Save, ...
Journal of global antimicrobial resistance 19, 255-261, 2019
462019
Resistance development to bacteriophages occurring during bacteriophage therapy. Viruses 10: 351
F Oechslin, F Oechslin
392018
Phage endolysins are adapted to specific hosts and are evolutionarily dynamic
F Oechslin, X Zhu, MB Dion, R Shi, S Moineau
PLoS biology 20 (8), e3001740, 2022
292022
Aspirin plus ticlopidine prevented experimental endocarditis due to Enterococcus faecalis and Streptococcus gallolyticus
TR Veloso, F Oechslin, YA Que, P Moreillon, JM Entenza, S Mancini
Pathogens and disease 73 (8), ftv060, 2015
272015
Temperate Prophages Increase Bacterial Adhesin Expression and Virulence in an Experimental Model of Endocarditis Due to Staphylococcus aureus From the …
F Laumay, AR Corvaglia, SM Diene, M Girard, F Oechslin, ...
Frontiers in microbiology 10, 742, 2019
252019
Bacterial resistance to phage and its impact on clinical therapy
S McCallin, F Oechslin
Phage therapy: a practical approach, 59-88, 2019
202019
The potential of bacteriophages to control Xanthomonas campestris pv. campestris at different stages of disease development
D Holtappels, KJ Fortuna, L Moons, N Broeckaert, LE Bäcker, ...
Microbial biotechnology 15 (6), 1762-1782, 2022
182022
The multidomain architecture of a bacteriophage endolysin enables intramolecular synergism and regulation of bacterial lysis
F Oechslin, C Menzi, P Moreillon, G Resch
Journal of Biological Chemistry 296, 2021
182021
Marginal role of von Willebrand factor-binding protein and coagulase in the initiation of endocarditis in rats with catheter-induced aortic vegetations
S Mancini, F Oechslin, C Menzi, YA Que, J Claes, R Heying, TR Veloso, ...
Virulence 9 (1), 1615-1624, 2018
112018
Antibodies targeting Hsa and PadA prevent platelet aggregation and protect rats against experimental endocarditis induced by Streptococcus gordonii
S Mancini, C Menzi, F Oechslin, P Moreillon, JM Entenza
Infection and immunity 84 (12), 3557-3563, 2016
92016
Antibiotic exposure leads to reduced phage susceptibility in vancomycin intermediate Staphylococcus aureus (VISA)
S McCallin, C Menzi, S Lassen, J Daraspe, F Oechslin, P Moreillon
Antimicrobial Agents and Chemotherapy 66 (7), e02247-21, 2022
32022
Fermentation practices select for thermostable endolysins in phages
F Oechslin, X Zhu, C Morency, V Somerville, R Shi, S Moineau
Molecular Biology and Evolution 41 (3), msae055, 2024
12024
The system can't perform the operation now. Try again later.
Articles 1–20